Dasatinib induces severe hemorrhagic colitis in a patient with accelerated phase of chronic myelogenous leukemia.

Author: Eunjung YIM ¹ ; Yeon Geun CHOI ; Yoon Jeong NAM ; Jain LEE ; Jeong A KIM
Author Information

1. Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea. jakim@catholic.ac.kr
Publication Type:Letter
Keywords: Hemorrhagic colitis; Dasatinib; Leukemia, myelogenous, chronic, BCR-ABL positive
MeSH: Colitis*; Dasatinib*; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
From:The Korean Journal of Internal Medicine 2018;33(2):446-448
CountryRepublic of Korea
Language:English
Abstract: No abstract available.